Market Trends JNJ met main goal in late-stage trial for ulcerative colitis treatment (JNJ:NYSE)By admin8996erT0allFebruary 21, 2025 Rasi BhadramaniJohnson & Johnson (JNJ) said on Friday that its late-stage study of TREMFYA as an induction therapy for adults…
Market Trends Novo Nordisk reports interim results from late-stage trial of its haemophilia A treatmentBy admin8996erT0allFebruary 7, 2025 ismagilov Novo Nordisk announced interim results from the phase 3 FRONTIER3 trial of 70 children (aged 1-11 years old) with…
Market Trends Stoke Therapeutics to initiate late-stage study for the treatment of Dravet syndromeBy admin8996erT0allJanuary 7, 2025 designer491/iStock via Getty Images Stoke Therapeutics (NASDAQ:STOK) announced alignment with global regulatory agencies on the design of the company’s Phase…
